According to the Susan G. Komen website, breast cancer mortality has declined by 39%, yet 266,120 new cases of breast cancer (for women and 2,550 for men) will be diagnosed this year. Insurance companies will look at the entire breast cancer history (including pathology reports), and some will be more favorable than others. That's where working with MVP Financial can help...
Underwriting the mortality risk for breast cancer varies with the stage of the cancer. Non-invasive cancer has a better diagnosis than invasive tumors. Tumor size is an independent foretelling factor and each involved lymph node worsens the prognosis. Lifelong follow-up is required by the patient to detect relapses, which can occur decades after the initial diagnosis. Good and consistent medical follow up by your client will provide the full picture and is extremely important to the underwriting process.
To get started with the underwriting process, use this Breast Cancer Questionnaire from NAILBA for your clients that have been diagnosed with breast cancer and contact MVP Financial.
~There is never a guarantee of insurability and every case is handled individually.
~There is never a guarantee of insurability and every case is handled individually.
No comments:
Post a Comment